Dalkh, Tserendagva, et al. “Effects of Hepaclin-4 on Hepatocellular Carcinoma (Hep G2)”. Central Asian Journal of Medical Sciences, vol. 4, no. 1, Mar. 2018, pp. 48-54, doi:10.24079/cajms.2018.03.006.